.

Deeper Knowledge, Faster

  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Baxter
Novartis
Citi
Teva
AstraZeneca
Express Scripts
Boehringer Ingelheim
McKinsey
Federal Trade Commission

Generated: June 24, 2017

DrugPatentWatch Database Preview

OSMOVIST 240 Drug Profile

« Back to Dashboard

Which patents cover Osmovist 240, and what generic Osmovist 240 alternatives are available?

Osmovist 240 is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in OSMOVIST 240 is iotrolan. Additional details are available on the iotrolan profile page.

Summary for Tradename: OSMOVIST 240

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list16
Clinical Trials: see list677
Patent Applications: see list530
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OSMOVIST 240 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare
OSMOVIST 240
iotrolan
INJECTABLE;INTRATHECAL019580-002Dec 7, 1989DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Chubb
Chinese Patent Office
Healthtrust
Boehringer Ingelheim
Citi
Fuji
Moodys
Queensland Health
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot